156 results on '"Alekseev, K. V."'
Search Results
2. Optimization Using Regression Analysis of the Wet Granulation Process for Production of GSB-106 Tablets
3. Modern Approaches to Mathematical Modeling of the Process of Direct Pressing of Tablets
4. Formulating GML-1 Tablets Using the Harrington Desirability Function
5. Study of the Pressing Process of N-Butyl-N-Methyl-1-Phenylpyrrolo-[1,2-a]Pyrazine-3-Carboxamide (GML-3) Tablets Using Mathematical Modeling Techniques
6. Advanced Taste-Masking Methods of Solid Dosage Forms
7. Application of Mixing Indices in Modeling Processes in Pharmaceutical Production
8. Evaluation and Analysis of Mathematical Models of Heat-Transfer Processes Occurring Upon Application of Film Coatings on Biconvex Tablets
9. Modern Approaches to Obtaining Floating Drug Dosage Forms (A Review)
10. Peculiarities of the Application of Mathematical Models Describing Mass-Transfer Processes in Film Coating Technology for a Biconvex Tablet
11. Oral Dispersible Tablets of GK-2 [bis-(N-Monosuccinyl-L-Glutamyl-L-Lysine) Hexamethyleneamide]: Optimization of Pressing Process by Mathematical Modeling Based on the Heckel and Kawakita Equations
12. Use of Two-Factor Dispersion Analysis for Studying the Pharmaceutical and Technological Properties of Tablets of GK-2 – bis-(N-Monosuccinyl-L-Glutamyl-L-Lysine) Hexamethyleneamide, Dispersed in the Oral Cavity
13. Application of the Kuenz–Leuenberger Equation as a Predictive Model of the Direct Tablet Compression Process
14. Modeling the Desorption Stage in Lyophilization Technology of bis(N-Monosuccinyl-L-Glutamyl-L-Lysine) Hexamethylenediamide (GK-2)
15. Development and Study of Anxiolytic Effect of Gml-1 Tablet Dosage Form
16. Comparative Pharmacokinetics and Relative Bioavailability of a New Anxiolytic GML-1 in Tablet Form
17. Features of risk analysis, assessment and control methods in pharmaceutical development
18. Antidepressant Effect of a Dipeptide Brain-Derived-Neurotrophic-Factor Mimetic (GSB-106) in a Generic Oral Dosage Form
19. Molecular-genetic and biochemical characteristics of citrate synthase from the citric-acid producing fungus Aspergillus niger
20. Preclinical Pharmacokinetic and Pharmacodynamic Studies of Pharmaceutical Compositions of the Dipeptide Anxiolytic GB-115
21. On locating a vacuum leak with the indicator fiber particle method
22. Evolution of a dust cloud in the field of a Knudsen flow under zero gravity conditions (numerical scenarios)
23. Metabolic characteristics of citric acid synthesis by the fungus Aspergillus niger
24. Analytical Method Development for Tablets of the New Kappa-Opioid Agonist RU-1205
25. Influence of Microencapsulation Process Parameters on Naltrexone Prolonged-Release Dosage Form
26. APPLICATION OF MULTIVARIATE ANOVA AND GENERALIZED DESIRABILITY TO OPTIMIZE THE COMPOSITION AND TECHNOLOGY OF TABLETS CONTAINING N-BENZYL-N-METHYL-1-PHENYLPYRROLO [1,2-A] PYRAZINE-3-CARBOXAMIDE
27. Pharmacokinetic study of original and generic levofloxacin tablets
28. Development of formulation, manufacturing technology, and standardization of solid pharmaceutical dosage form of Dilept, a novel atypical neuroleptic
29. Rheological properties of an original pharmaceutical composition of a nanostructured silver system stabilized by arabinogalactan
30. DEVELOPMENT OF PERORAL HYPOLIPIDEMIC FORMULATION BASED ON SULFATED ARABINOGALACTAN IN THE FORM OF POTASSIUM SALT
31. USING THE SeDeM-ODT METHOD FOR THE DEVELOPMENT OF GK-2 TABLETS DISPERSED IN THE ORAL CAVITY
32. Limiting self-similar motion of a solid particle in a free-molecular gas flow escaping from an orifice
33. HPLC Determination of foreign impurities in tropoxin parent substance and tablets
34. Perspectives of the development of pharmaceutical nanotechnology
35. Developing analytical techniques for GB-115 determination in solid dosage form (tablets)
36. Polymers in the formulation of drug dosage forms with modified release
37. Pharmaceutical analysis and standardization of gimantan parenteral dosage form
38. Pharmaceutical analysis and standardization of noopept tablets
39. Quantitative determination of himantane in rat blood plasma
40. Preparation and evaluation of bioavailability of gatifloxacine-loaded nanoparticles
41. Pharmaceutical analysis and standardization of afobazole in solid dosage form (tablets)
42. Developing analytical methods for afobazole in injection forms
43. Developing methods for analysis of the solid dosage form (capsules) of cardiocyclide
44. Handwritten signature verification based on code representation
45. Development and comparative evaluation of a new liposomal dermatological preparation based on Viton oil
46. Absolute Bioavailability of Himantane in Rabbits
47. Application of the blood sedimentation processes as nonspecific biosensors for the bioequivalence monitoring of pharmaceutical compositions on the basis of one chemical entry (acetylsalicylic acid)
48. SPECIAL ASPECTS OF THE TECHNOLOGY OF MEDICATED CHEWING GUM PRODUCTION
49. DRUG SYNTHESIS METHODS AND MANUFACTURING TECHNOLOGY: DEVELOPMENT AND COMPARATIVE EVALUATION OF A NEW LIPOSOMAL DERMATOLOGICAL PREPARATION BASED ON VITON OIL
50. MODIFICATION OF ADDITIVE TECHNOLOGIES FOR OBTAINING MEDICAL FORMS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.